Anil Gulati

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Journal of clinical medicine

International journal of molecular sciences

Scientific reports

Antimicrobial agents and chemotherapy

Pharmazz, Inc.

Erasmus University Rotterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharmazz, Inc.

United States

Chairman and CEO

Education History

Erasmus University Rotterdam

Netherlands

PHD

Publications

Aman Khanna, Krish Vaidya, Dharmesh Shah, Amaresh K Ranjan, Anil Gulati
Centhaquine Increases Stroke Volume and Cardiac Output in Patients with Hypovolemic Shock. Journal of clinical medicine 13 (13) (2024)
Athanasios Chalkias, Gwendolyn M Pais, Anil Gulati
Effect of Centhaquine on the Coagulation Cascade in Normal State and Uncontrolled Hemorrhage: A Multiphase Study Combining Ex Vivo and In Vivo Experiments in Different Species. International journal of molecular sciences 25 (6) (2024)
Athanasios Chalkias, Gwendolyn M Pais, Anil Gulati
Effect of Centhaquine on the Coagulation Cascade in Normal State and Uncontrolled Hemorrhage: A Multiphase Study Combining Ex Vivo and In Vivo Experiments in Different Species. International journal of molecular sciences 25 (6) (2024)
Athanasios Chalkias, Gwendolyn M Pais, Anil Gulati
Effect of Centhaquine on the Coagulation Cascade in Normal State and Uncontrolled Hemorrhage: A Multiphase Study Combining Ex Vivo and In Vivo Experiments in Different Species. International journal of molecular sciences 25 (6) (2024)
Aman Khanna, Krish Vaidya, Dharmesh Shah, Amaresh K Ranjan, Anil Gulati
Centhaquine Increases Stroke Volume and Cardiac Output in Patients with Hypovolemic Shock. Journal of clinical medicine 13 (13) (2024)
Amaresh K Ranjan, Anil Gulati
Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock. Journal of clinical medicine 12 (3) (2023)
Amaresh K Ranjan, Anil Gulati
Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock. Journal of clinical medicine 12 (3) (2023)
Amaresh K Ranjan, Anil Gulati
Advances in Therapies to Treat Neonatal Hypoxic-Ischemic Encephalopathy. Journal of clinical medicine 12 (20) (2023)
Amaresh K Ranjan, Anil Gulati
Controls of Central and Peripheral Blood Pressure and Hemorrhagic/Hypovolemic Shock. Journal of clinical medicine 12 (3) (2023)
Amaresh K Ranjan, Anil Gulati
Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders. International journal of molecular sciences 23 (6) (2022)
Anil Gulati, Rajat Choudhuri, Ajay Gupta, Saurabh Singh, S K Noushad Ali, Gursaran Kaur Sidhu, Parvez David Haque, Prashant Rahate, Aditya R Bothra, Gyan P Singh, Sanjiv Maheshwari, Deepak Jeswani, Sameer Haveri, Apurva Agarwal, Nilesh Radheshyam Agrawal
A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients. Drugs 81 (9) (2021)
Anil Gulati, Rajat Choudhuri, Ajay Gupta, Saurabh Singh, S K Noushad Ali, Gursaran Kaur Sidhu, Parvez David Haque, Prashant Rahate, Aditya R Bothra, G P Singh, Sanjeev Maheshwari, Deepak Jeswani, Sameer Haveri, Apurva Agarwal, Nilesh Radheshyam Agrawal
A multicentric, randomized, controlled phase III study of centhaquine (Lyfaquin ® ) as a resuscitative agent in hypovolemic shock patients. medRxiv : the preprint server for health sciences (2021)
Anil Gulati, Nilesh Agrawal, Deepti Vibha, U K Misra, Birinder Paul, Dinesh Jain, Jeyaraj Pandian, Rupam Borgohain
Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke. CNS drugs 35 (1) (2021)
Anil Gulati, Dinesh Jain, Nilesh Radheshyam Agrawal, Prashant Rahate, Rajat Choudhuri, Soumen Das, Deba Prasad Dhibar, Madhav Prabhu, Sameer Haveri, Rohit Agarwal, Manish S Lavhale
Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial. Advances in therapy 38 (6) (2021)
Seema Briyal, Amaresh K Ranjan, Mary G Hornick, Anupama K Puppala, Thanh Luu, Anil Gulati
Author Correction: Anti-apoptotic activity of ETB receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia. Scientific reports 10 (1) (2020)
Seema Briyal, Amaresh K Ranjan, Mary G Hornick, Anupama K Puppala, Thanh Luu, Anil Gulati
Anti-apoptotic activity of ETB receptor agonist, IRL-1620, protects neural cells in rats with cerebral ischemia. Scientific reports 9 (1) (2019)
Medha D Joshi, Gwendolyn M Pais, Jack Chang, Khrystyna Hlukhenka, Sean N Avedissian, Anil Gulati, Walter C Prozialeck, Peter C Lamar, Zhong Zhang, Marc H Scheetz, Brooke Griffin
Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model. Antimicrobial agents and chemotherapy 63 (10) (2019)

Anil Gulati.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anil Gulati